New research of over 300 documents reveals a mixed bag of evidence surrounding the controversial 340B Drug Pricing Program’s impact on the U.S. healthcare system, a study published Nov. 22 in JAMA Health Forum found.
Category: Static
Sutter creates new C-suite role
Sacramento, Calif.-based Sutter Health has appointed Dana Beckton as its first chief diversity and inclusion officer, effective Jan. 8
Eli Lilly creates space for San Diego healthcare startups
Pharmaceutical giant Eli Lilly is opening an accelerator and co-working space for biotech companies in San Diego.
Mark Cuban drug company taps mail-order pharmacy
Mark Cuban Cost Plus Drug Co. is teaming up with PharmcoRx, a pharmacy services business, to expand its pharmacy affiliate network.
RaDonda Vaught reflects on criminal case
RaDonda Vaught shared new details about her criminal case and life since her conviction in a two-part podcast from “Nurses Uncorked” released Nov. 21.
Tampa General to support cancer innovation with IT resources, venture capital
Tampa (Fla.) General Hospital is offering IT resources and venture capital funding to innovative solutions aiming to transform cancer care.
Siemens to lay off 300 employees
Siemens Healthineers is laying off hundreds of employees in New Jersey, according to a state filing.
Mass General Brigham adopts radiology AI 'copilot' from Microsoft
Somerville, Mass.-based Mass General Brigham is one of the first health systems to use a new generative artificial intelligence-powered radiology “copilot” from Microsoft subsidiary Nuance.
3 face trial for role in nurse degree scheme
Three defendants will face a jury trial in Fort Lauderdale, Fla., starting Nov. 29 for their role in a coordinated scheme to sell thousands of fraudulent diplomas and transcripts to aspiring nurses, which enabled them to sit for the National Council Li…
RSV drug supply woes prompt White House team to meet with suppliers
The White House is pressing suppliers to meet the demand “with a sense of urgency” after drugmakers underestimated the demand for Beyfortus, the first respiratory syncytial virus drug for children.
